About ubrogepant
CGRP receptor antagonist
Used for
- Treats migraine attacks, with or without aura, in adults.
Usual adult dose
50 mg or 100 mg by mouth; may repeat once after at least 2 hours. Maximum 200 mg in 24 hours.
Common side effects
Important warnings
- Not for preventing migraines or treating cluster headaches.
- Avoid with strong CYP3A4 inhibitors or inducers.
- Dose changes may be needed with certain medicines or severe liver or kidney problems.
Pregnancy
Human pregnancy information is limited; safety is not established.
Breastfeeding
It is unknown whether ubrogepant passes into breast milk; information is limited.
Interactions
- Strong CYP3A4 inhibitors can greatly increase ubrogepant levels.
- Strong CYP3A4 inducers can reduce its effect.
- Avoid with other medicines that strongly affect CYP3A4.
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.